GP120 Antikörper (HRP)
(1 reference)-
- Target Alle GP120 (HIV-1 gp120) Antikörper anzeigen
- GP120 (HIV-1 gp120) (Human Immunodeficiency Virus 1 Surface Glycoprotein (HIV-1 gp120))
-
Reaktivität
- Human Immunodeficiency Virus (HIV)
-
Wirt
- Ziege
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser GP120 Antikörper ist konjugiert mit HRP
-
Applikation
- ELISA, Western Blotting (WB), Immunohistochemistry (Frozen Sections) (IHC (fro))
- Produktmerkmale
- Purified IgG conjugated to Horseradish Peroxidase (HRP)
- Immunogen
- Purified gp120, from strain IIIB
- Isotyp
- IgG
- Top Product
- Discover our top product HIV-1 gp120 Primärantikörper
-
anti-Human Immunodeficiency Virus 1 Surface Glycoprotein (HIV-1 gp120) (AA 255-477) antibody
HIV-1 gp120 Reaktivität: Human Immunodeficiency Virus (HIV) ELISA, WB Wirt: Maus Monoclonal 3F9 unconjugated
anti-Human Immunodeficiency Virus 1 Surface Glycoprotein (HIV-1 gp120) (AA 255-477) antibodyHIV-1 gp120 Reaktivität: Human Immunodeficiency Virus (HIV) ELISA, WB Wirt: Maus Monoclonal 3F8 unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1.0 mg/mL
-
-
: "HIV-1 acute infection env glycomutants designed from 3D model: effects on processing, antigenicity, and neutralization sensitivity." in: Virology, Vol. 324, Issue 1, pp. 90-102, (2004) (PubMed).
-
: "HIV-1 acute infection env glycomutants designed from 3D model: effects on processing, antigenicity, and neutralization sensitivity." in: Virology, Vol. 324, Issue 1, pp. 90-102, (2004) (PubMed).
-
- Target
- GP120 (HIV-1 gp120) (Human Immunodeficiency Virus 1 Surface Glycoprotein (HIV-1 gp120))
- Andere Bezeichnung
- HUMAN IMMUNODEFICIENCY VIRUS 1 Gp120 (HIV-1 gp120 Produkte)
- Substanzklasse
- Viral Protein
- Hintergrund
- Synonyms: HIV-1
- UniProt
- Q70626
-
